ADITXT INC has amended its merger agreement with Evofem Biosciences, adjusting investment amounts and timelines, and completed a 1-for-40 reverse stock split effective October 1, 2024.
AI Assistant
ADITXT INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.